SELLAS Life Sciences (SLS) stock falls following interim results from a Phase 3 REGAL trial for its lead asset, galinpepimut-S (GPS) in blood cancer. Read more here.

Black Americans have double the risk of developing multiple myeloma compared to white Americans and are diagnosed at younger ...

SELLAS Life Sciences CEO Angelos Stergiou joined 'Fox & Friends' to discuss how artificial intelligence has positively impacted medicine as his company works to develop a vaccine for leukemia.

Investing.com -- SELLAS Life Sciences stock fell 14% following the outcome of the interim analysis for its pivotal Phase 3 REGAL trial of GPS in Acute Myeloid Leukemia (AML). The Independent (LON: IOG ...

OGT announces the North American launch of its new next-generation sequencing (NGS) SureSeq™ Myeloid MRD Panel, which ...

The community is stepping up to support his family as they navigate a financially and emotionally draining time.

A local 7-year-old is at the forefront of many minds in the Lewisville area, as her family and community plan a fundraiser after she was diagnosed with a rare blood disorder that eventually leads to ...

The Police Officers Coalition is asking for donations for an officer's son who has been diagnosed with cancer.

Shares were up 30% to 5.18 Canadian dollars Wednesday. Medexus will target a commercial launch in the first half of calendar 2025. The company believes product-level revenue in the U.S. has the ...